verbatim): Re-endothelialization (rET) at sites of spontaneous or iatrogenic disruption has classically been considered to result from the migration and proliferation of endothelial cells (ECs) from endothelium adjacent to the site of injury, including endothelium lining the branch vessels which originate within the injured vascular segment. Preliminary data from our laboratory and others', however, suggests that neighboring ECs may not constitute the exclusive basis for endothelial repair. These studies suggest that circulating cells derived from the bone marrow (BM) and exhibiting phenotypic features of ECs are capable of homing to sites of arterial injury and incorporating into neoendothelium. Accordingly, the goal of the studies outlined in this proposal is to delineate the contribution of BM-derived endothelial progenitor cells (EPCs) to the maintenance and repair of vascular endothelium. The proposed experiments have been designed to test specific hypotheses, organized according to three Specific Aims. The first Specific Aim is to establish definitive evidence regarding the BM origin of EPCs which incorporate into neoendothelium. These experiments will be performed in murine and rodent models of arterial injury following transplantation of BM from Tie2/LacZ transgenic mice to immunodeficient animals.
Specific Aim 2 is designed to investigate the impact of systemic pathology on EPC kinetics and incorporation.
Specific Aim 3 is organized to explore the impact of EC mitogens, EC antagonists, and genetic engineering on EPC incorporation into neoendothelium.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Sopko, George
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
St. Elizabeth's Medical Center of Boston
United States
Zip Code
Morishita, Yoshihiro; Kobayashi, Koichi; Klyachko, Ekaterina et al. (2016) Wnt11 Gene Therapy with Adeno-associated Virus 9 Improves Recovery from Myocardial Infarction by Modulating the Inflammatory Response. Sci Rep 6:21705
Sekiguchi, Haruki; Ii, Masaaki; Jujo, Kentaro et al. (2013) Estradiol promotes neural stem cell differentiation into endothelial lineage and angiogenesis in injured peripheral nerve. Angiogenesis 16:45-58
Masuda, Haruchika; Asahara, Takayuki (2013) Clonogenic assay of endothelial progenitor cells. Trends Cardiovasc Med 23:99-103
Jujo, Kentaro; Ii, Masaaki; Sekiguchi, Haruki et al. (2013) CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism. Circulation 127:63-73
Mackie, Alexander R; Klyachko, Ekaterina; Thorne, Tina et al. (2012) Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction. Circ Res 111:312-21
Sekiguchi, Haruki; Ii, Masaaki; Jujo, Kentaro et al. (2012) Estradiol triggers sonic-hedgehog-induced angiogenesis during peripheral nerve regeneration by downregulating hedgehog-interacting protein. Lab Invest 92:532-42
Masuda, Haruchika; Iwasaki, Hiroto; Kawamoto, Atsuhiko et al. (2012) Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis. Stem Cells Transl Med 1:160-71
Losordo, Douglas W; Kibbe, Melina R; Mendelsohn, Farrell et al. (2012) A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia. Circ Cardiovasc Interv 5:821-30
Nishimura, Yukihide; Ii, Masaaki; Qin, Gangjian et al. (2012) CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice. J Invest Dermatol 132:711-20
Sahoo, Susmita; Klychko, Ekaterina; Thorne, Tina et al. (2011) Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res 109:724-8

Showing the most recent 10 out of 89 publications